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dressings, a pressure reducing surface, repositioning, and
debridement.
RESULTS: Our modeling predicted the total expected cost
of standard care treatment for a stage 3 pressure ulcer to
be $20,874. Randomized clinical trials have found that
NNWT (n  72 patients) decreases the surface area of
stage 3-4 pressure ulcers by 2.5 fold (SD 59%) over stan-
dard care (n  59 patients). The eight-week healing rates
for stage 3 ulcers are 71% with NNWT and 54% for stan-
dard care. At these healing rates, our modeling for stage 3
pressure ulcers found that for a 40 month time frame
NNWT saves $6,630 (SE $98) and increases QALYs by
0.10 (SE 0.0005) life years compared to standard care. For
stage 4 pressure ulcers, NNWT saves $15,216(SE $186)
and increases QALYs by 0.14 (SE 0.001).
CONCLUSIONS: NNWT in patients with stage 3 and 4
pressure ulcer is an economically attractive intervention.
Additional well-controlled clinical trials are necessary to
further define the role of NNWT in the care of chronic
wounds.
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Psoriasis is a chronic disease, which affects 4.7 % of the
French population. Even if it is not a question of a vital
prognosis, it is a very invalidating condition in daily life
because of the damage to the body image.
OBJECTIVE: Evaluate the Quality of Life consequences
for patients with psoriasis, in France.
METHOD: Four thousand five hundred anonymous
questionnaires were sent, via a Patient Support Group
acting against Psoriasis (Association Pour la Lutte Contre
le Psoriasis, APLCP). The questionnaires consisted of two
scales: the Psoriasis Disability Index and 10 questions
concerning the treatment and evolution of psoriasis.
RESULTS: Twenty-five days after the mailing, 2014
questionnaires (44%) were received. An analysis of the
first questionnaire was conducted. The respondents were
54% women, average age was 50 years, and for men, 53
years. The average age at diagnosis for men was 30 years,
and for women, 25 years. Women are significantly more
adversely affected than men in their everyday activities.
Men are significantly more adversely affected than women
at work. No difference was observed between men’s and
women’s global scores. Psoriasis seems to incapacitate 16
to 55 year olds in their social relations, leisure activities
and how well they keep their house more than it does
older subjects. Long-standing psoriasis does not seem to
be more of a handicap to people than more recent psoria-
sis. The global score is similar. However, a clear trend is
observed between the age at the moment of diagnosis and
the level of incapacity (p  .0176). The younger the indi-
vidual in which psoriasis is diagnosed, the higher the level
of incapacity. This is particularly marked in terms of the
everyday and leisure scores.
CONCLUSION: These results highlight the value of ap-
propriate and relevant psychological and medical envi-
ronment for children suffering from psoriasis.
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OBJECTIVE: For patients with atopic dermatitis, long-
term treatment is usually unavoidable and various limita-
tions are caused in their daily life. Therefore, the influ-
ence on the patient of new, innovative pharmacotherapy
for atopic dermatitis is thought to be extremely large
from an economic viewpoint. In this study, we attempted
to measure willingness to pay (WTP) for the newly devel-
oped therapeutic agent, “tacrolimus”.
METHODS: 1,000 men and women, 20–59 years old and
living in the Tokyo metropolitan area, were selected by
random sampling for the interview survey. The bidding
game method and the take-it-or-leave-it approaches were
adopted. Eight patterns of health-care costs for one month
(from 625 to 80,000 yen) were allocated to each respon-
dent at random to avoid “starting point bias”. We esti-
mated the demand curve, assuming that the log transfor-
mation of WTP will be distributed as a logistic function.
RESULTS: A total of 431 interviews (43.1% of the can-
didates) were completed. More than half responded as
“yes” to the price of 10,000 yen or less. The demand
curve was estimated to be: P(x)1/(1  exp(5.5239 
0.5906 ln(x))). The median of WTP was 11,537 yen
(95% CI: 8,967–14,845).
CONCLUSION: It can be interpreted that the average
amount people are willing to pay for tacrolimus pharma-
cotherapy is 11,500 yen a month. This information is
considered to be beneficial for clinical decision-making as
well as policy decision-making such as price setting and
reimbursement decisions.
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OBJECTIVE: The Family Hardiness Index (FHI) has
been used to glean insight into the functionality of the
